Task Evidence
HER2-Tumor-ROIs · treatment_response (HER2-Tumor-ROIs__response)
Risk, Response & Prognosis / Treatment Response & Residual Disease
Inspect benchmark evidence for one task at a time: who leads, how stable the split-level results are, and which neighbouring tasks are likely to transfer intuition.
clsL1 · Risk, Response & PrognosisL2 · Treatment Response & Residual DiseasebreastH&EInformative evidence
Task metadata
Fields sourced from benchmark_main. Missing values are shown as —.
Identity
- task_key
- HER2-Tumor-ROIs__response
- dataset_name
- HER2-Tumor-ROIs
- task_name
- treatment_response
- task_type
- cls
Taxonomy
- task_family_l1
- Risk, Response & Prognosis
- task_family_l2
- Treatment Response & Residual Disease
- label_structure
- binary
- num_classes
- 2
- labels
- {"0": "negative", "1": "positive"}
Biology
- organ
- breast
- stain
- H&E
- specimen_type
- biopsy
- timepoint
- pre_treatment
- disease
- 乳腺癌
Scale & Labels
- patient_n
- 85
- slide_n
- 85
- label_source
- clinical_outcome
- label_visibility
- distal
Result Evidence
- result_tier
- Informative
- result_quality_score
- 74.3
- result_flags
- config_sensitive
- result_tier_reason
- Clear model separation: significant-win density 0.185.Difficulty sits in a usable range: best mean 0.730.Leader changes across checkpoint strategies: 3 distinct leaders.
loading…
Similar tasks
Ranked by shared L2 subtype first, then L1 family, organ, type and label structure.
- BC-Therapy · residual_cancer_burdenL1 · Risk, Response & PrognosisL2 · Treatment Response & Residual Diseasebreastclsscore 13has results
- MBC · recist_responseL1 · Risk, Response & PrognosisL2 · Treatment Response & Residual Diseasebreastclsscore 13has results
- OV-Bevacizumab · treatment_responseL1 · Risk, Response & PrognosisL2 · Treatment Response & Residual Diseaseovaryclsscore 11has results
- PTRC-HGSOC · treatment_responseL1 · Risk, Response & PrognosisL2 · Treatment Response & Residual Diseaseovaryclsscore 11has results
- PTRC-HGSOC · tumor_stageL1 · Risk, Response & PrognosisL2 · Treatment Response & Residual Diseaseovaryclsscore 11has results
- CHIMERA2025 · brs_risk_groupL1 · Risk, Response & PrognosisL2 · Treatment Response & Residual Diseasebladderclsscore 10has results
- NADT-Prostate · treatment_responseL1 · Risk, Response & PrognosisL2 · Treatment Response & Residual Diseaseprostateclsscore 10has results
- AURORA-MBC · hla_a_alteration_statusL1 · Biomarker & Molecular ProfilingL2 · Genomic, Epigenetic & Pathway Alterationsbreastclsscore 7has results